The Peptide Market Hits $140 Billion: Industry Report 2026

The global peptide therapeutics market reached approximately $140.86 billion in 2025, driven primarily by the explosive growth of GLP1 receptor agonists for diabetes and obesity. With 80+ FDAapproved peptide drugs, 150+ in clinical trials, and a projected market of $294 billion by 2033, the peptide industry is one of the fastestgrowing segments in global pharmaceuticals — but a widening quality gap in researchgrade supply is creating structural tensions.

For research use only. Not for human consumption.